Clinical Trial Update: Ketamine and Hydromorphone for Patient Controlled Pain Relief in Children's Mucositis [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating ketamine and hydromorphone for patient-controlled analgesia in pediatric mucositis has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Mucositis

Drugs mentioned

• Hydromorphone (hydromorphone)
• Ketamine (ketamine)

Snippet

Sponsor: University of British Columbia | Conditions: Mucositis | Phase 3 | Status: WITHDRAWN